Alexion Pharmaceuticals Inc (ALXN)

ALXN (NASDAQ:Drugs) EQUITY
$125.97
pos +0.35
+0.28%
Today's Range: 123.13 - 126.69 | ALXN Avg Daily Volume: 2,203,300
Last Update: 12/08/16 - 3:59 PM EST
Volume: 1,914,165
YTD Performance: -34.14%
Open: $125.45
Previous Close: $125.62
52 Week Range: $110.56 - $205.29
Oustanding Shares: 224,247,998
Market Cap: 27,844,873,912
6-Month Chart
TheStreet Ratings Grade for ALXN
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 12 11 12 11
Moderate Buy 2 2 2 2
Hold 6 7 5 4
Moderate Sell 0 0 0 0
Strong Sell 0 0 1 0
Mean Rec. 1.67 1.77 1.77 1.56
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 302.85
Price Earnings Comparisons:
ALXN Sector Avg. S&P 500
302.85 75.70 0.00
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
0.42% -29.88% 0.14%
GROWTH 12 Mo 3 Yr CAGR
Revenue 16.60 1.30 0.32
Net Income -78.00 -0.40 -0.17
EPS -79.40 -0.50 -0.20
Earnings for ALXN:
EBITDA 0.86B
Revenue 2.60B
Average Earnings Estimates
Qtr (12/16) Qtr (03/17) FY (12/16) FY (12/17)
Average Estimate $1.10 $n.a. $3.86 $4.80
Number of Analysts 1 0 1 1
High Estimate $1.10 $n.a. $3.86 $4.80
Low Estimate $1.10 $n.a. $3.86 $4.80
Prior Year $0.84 $0.87 $4.55 $3.86
Growth Rate (Year over Year) 30.95% n.a.% -15.16% 24.35%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands

bullishAlexion upgraded at Barclays

Nov 29, 2016 | 7:48 AM EST
ALXN was upgraded from Equal-weight to Overweight, Barclays said. $155 price target. Company has multiple potential catalysts for 2017.
RMPIA
By

Jim Cramer

 | Nov 4, 2016 | 11:59 AM EDT
Jim Cramer explains the recent moves in biotechs and comments on reports regarding a Justice Department investigation into generic drug makers.
RMPIA
By

Guy Ortmann

 | Oct 31, 2016 | 12:19 PM EDT
Here's a window into what institutional investors may be doing and how to profit from that.

bullishAlexion upgraded at Goldman

Oct 28, 2016 | 8:02 AM EDT
ALXN was upgraded from Neutral to Buy, Goldman Sachs said. $158 price target. '1210 product could be more effective and have different dosing than its competition.

bullishAlexion upgraded at Credit Suisse

Jul 11, 2016 | 7:57 AM EDT
ALXN was upgraded from Neutral to Outperform, Credit Suisse said. Valuation call, based on a $165 price target.
RMPIA
By

James "Rev Shark" DePorre

 | Jun 8, 2016 | 7:11 AM EDT

Too many turn bearish too quickly just because they can't find any entry points.

RMPIA
By

Bob Byrne

 | Jun 8, 2016 | 7:00 AM EDT

Big move for biotechs isn't pleasant.

RMPIA
By

Real Money

 | Jun 7, 2016 | 12:37 PM EDT

U.S. indices are up as oil continues its climb past $50 a barrel.

bullishAlexion upgraded at BMO

Apr 29, 2016 | 7:18 AM EDT

ALXN was upgraded to Outperform, BMO Capital said. $168 price target. Sell-off after earnings has created a buying opportunity.

By

Tony Owusu

 | Apr 28, 2016 | 8:34 AM EDT

Crude prices were also falling following the BOJ's decision to keep its monetary policy unchanged. 

Markets slightly up as we get closer to mid-day.  Oil barely holding $50 a barrel lev...
we'll roll DIS here and bank a win in COST SOLD DIS JAN 100 CALL A...
The great Skip Raschke joins me after the close to talk options, trading and other stuff h...
Big day for TWTR.  The stock is up over 6% with the help of a nice bump in volume.&nb...

REAL MONEY PRO'S BEST IDEAS

News Breaks

Powered by
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.